KAYLEE WILLIAMS: Open Payments
NPI 1073751723 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 18 payments from 9 companies in 2025. Trend: 2023 $169 · 2024 $167 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 4 | $84 |
| MILLICENT US INC | 3 | $66 |
| Exact Sciences Corporation | 3 | $57 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| EBI, LLC | 1 | $27 |
| Organon LLC | 1 | $27 |
| PFIZER INC. | 1 | $23 |
Products named: ZURZUVAE, INTRAROSA, Cologuard Collection Kit, Qelbree, Veozah, GARDASIL 9, BIOMET SPINALPAK NON-INVASIVE SPINE FUSION STIMULATOR SYSTEM, NEXPLANON.
Industry payments across TX — which companies pay providers there.
